PAPOTTI, Mauro Giulio
 Distribuzione geografica
Continente #
NA - Nord America 28.373
EU - Europa 17.863
AS - Asia 11.219
SA - Sud America 737
OC - Oceania 300
AF - Africa 246
Continente sconosciuto - Info sul continente non disponibili 32
Totale 58.770
Nazione #
US - Stati Uniti d'America 27.503
CN - Cina 5.093
IT - Italia 4.261
SG - Singapore 2.059
DE - Germania 1.931
IE - Irlanda 1.864
FR - Francia 1.556
SE - Svezia 1.498
UA - Ucraina 1.261
GB - Regno Unito 1.059
FI - Finlandia 1.049
KR - Corea 950
CA - Canada 669
JP - Giappone 664
AT - Austria 643
IN - India 635
PL - Polonia 618
VN - Vietnam 456
BR - Brasile 411
ES - Italia 401
TR - Turchia 342
NL - Olanda 325
AU - Australia 270
DK - Danimarca 217
ID - Indonesia 211
HK - Hong Kong 182
RU - Federazione Russa 182
MX - Messico 179
BE - Belgio 178
GR - Grecia 156
TW - Taiwan 129
AR - Argentina 123
CH - Svizzera 118
RO - Romania 112
PT - Portogallo 102
SN - Senegal 85
CO - Colombia 80
CZ - Repubblica Ceca 71
IL - Israele 64
SA - Arabia Saudita 56
TH - Thailandia 55
CL - Cile 54
PH - Filippine 52
MY - Malesia 50
NO - Norvegia 49
PK - Pakistan 47
HU - Ungheria 46
EG - Egitto 40
UZ - Uzbekistan 36
EU - Europa 31
IR - Iran 30
HR - Croazia 29
NZ - Nuova Zelanda 29
RS - Serbia 29
ZA - Sudafrica 28
DZ - Algeria 27
AE - Emirati Arabi Uniti 26
SI - Slovenia 25
EC - Ecuador 22
PE - Perù 21
SK - Slovacchia (Repubblica Slovacca) 17
VE - Venezuela 17
BG - Bulgaria 14
MU - Mauritius 13
MA - Marocco 11
NG - Nigeria 11
AM - Armenia 10
IQ - Iraq 9
JO - Giordania 9
LT - Lituania 9
TN - Tunisia 9
BY - Bielorussia 8
KZ - Kazakistan 8
MK - Macedonia 8
EE - Estonia 6
GT - Guatemala 6
BA - Bosnia-Erzegovina 5
PR - Porto Rico 5
SC - Seychelles 5
SD - Sudan 5
CY - Cipro 4
GE - Georgia 4
LB - Libano 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BD - Bangladesh 3
KW - Kuwait 3
LK - Sri Lanka 3
PA - Panama 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CU - Cuba 2
HN - Honduras 2
KG - Kirghizistan 2
Totale 58.739
Città #
Chandler 2.630
Beijing 2.579
Santa Clara 1.903
Dublin 1.830
Houston 1.751
Singapore 1.597
Fairfield 1.447
Ann Arbor 1.087
Ashburn 1.041
Torino 930
Wilmington 869
Jacksonville 819
Redwood City 800
Villeurbanne 751
Woodbridge 741
Seattle 629
Medford 597
Vienna 583
Princeton 578
Columbus 557
Nyköping 515
Cambridge 514
Dearborn 488
Warsaw 487
Pisa 423
Turin 367
Milan 332
Fremont 327
Boston 288
Shanghai 255
Guangzhou 244
Dong Ket 225
New York 216
Boardman 194
Nanjing 180
Jakarta 179
Tokyo 173
Toronto 171
Munich 154
Verona 146
Hangzhou 140
Rome 138
Helsinki 120
Seoul 114
Chicago 110
Norwalk 105
Pune 105
San Diego 100
Washington 96
Düsseldorf 93
Brussels 92
Montréal 90
London 83
Chengdu 82
Madrid 82
Los Angeles 81
Tappahannock 79
Falls Church 74
Wuhan 74
Shenyang 73
Zhengzhou 73
São Paulo 72
Hefei 71
Paris 69
Würzburg 69
Lachine 67
Phoenix 67
Taipei 66
Jinan 64
Bologna 63
Mcallen 63
Ottawa 63
Istanbul 62
Mountain View 62
Changsha 59
Kunming 59
Rochester 56
Ankara 55
Hong Kong 55
Nuremberg 55
Pittsburgh 55
Silver Spring 55
Buenos Aires 54
Athens 51
New Delhi 48
Central District 47
Santiago 46
Amsterdam 45
Padova 44
Barcelona 43
Birmingham 43
Dallas 42
Hebei 42
Bethesda 41
Frankfurt am Main 40
Moscow 40
Florence 39
Honolulu 39
Canberra 38
Sydney 38
Totale 33.688
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.389
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.145
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma 1.056
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 892
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 821
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 724
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 688
What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? 590
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 534
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied 476
Eccrine spiradenoma of the nipple: Case report, differential diagnosis and literature review 463
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 450
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 450
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 436
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 435
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 426
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 417
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 395
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas 391
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 390
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 354
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 352
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index - Which is the best predictor of prostate cancer after a negative biopsy? 342
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 335
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 331
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 329
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 326
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 324
Mesothelioma families without inheritance of a BAP1 predisposing mutation 320
Detection of EGFR mutations in archival lung cancer samples by pyrosequencing 319
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors 314
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations 314
An international Ki67 reproducibility study in adrenal cortical Carcinoma 308
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 302
Core biopsies of renal masses: a safe and accurate tool for managing all that is indeterminate 295
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 287
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 285
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 281
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 280
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 273
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 273
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 271
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC. 262
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 257
Adjuvant mitotane treatment for adrenocortical carcinoma 256
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 253
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 252
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 249
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 245
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 242
Morgana is a new oncosuppressor in CML 238
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 233
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 231
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 225
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 220
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 215
Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy 215
YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study 214
ELOVL5 Mutations Cause Spinocerebellar Ataxia 38 211
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 206
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 206
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 204
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. 203
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 202
Impact of COVID-19 lockdown measures on oncological surgical activity: Analysis of the surgical pathology caseload of a tertiary referral hospital in Northwestern Italy 199
Differentiation-inducing factor 1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and Thymidylate Synthase mRNAs accumulation 196
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 195
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 195
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines 193
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 191
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 185
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 184
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 183
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. 177
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 177
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 176
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 176
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 175
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 175
Updates on lung neuroendocrine neoplasm classification 171
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 171
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 170
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 167
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 163
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 161
Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract 158
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. 156
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 153
Classification of pulmonary neuroendocrine tumors: New insights 153
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. 149
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 148
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 146
Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal 146
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 144
mTOR/p70S6K in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. 141
Current state-of-the-art therapy for advanced squamous cell lung cancer 140
Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer 135
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 134
Thymidylate synthase expression in large cell carcinoma ofthe lung 133
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 133
Totale 30.371
Categoria #
all - tutte 171.851
article - articoli 0
book - libri 0
conference - conferenze 12.267
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.258 0 0 0 0 0 0 1.002 655 856 713 615 417
2020/20216.665 578 455 587 389 591 495 602 376 667 623 489 813
2021/20226.619 336 377 372 474 358 349 478 412 287 469 1.334 1.373
2022/20239.107 924 626 227 882 857 2.266 714 576 974 249 460 352
2023/20244.783 588 779 340 276 323 591 208 276 58 278 399 667
2024/20256.840 221 892 470 1.113 2.955 945 244 0 0 0 0 0
Totale 60.665